Interpace Diagnostics (IDXG) Tops Q4 EPS by 73c, Revenues Miss; Offers 1Q Revenue Guidance Below Consensus, Withdraws FY20 Guidance

Go back to Interpace Diagnostics (IDXG) Tops Q4 EPS by 73c, Revenues Miss; Offers 1Q Revenue Guidance Below Consensus, Withdraws FY20 Guidance
(AMEX: IDXG) Delayed: 1.63 --0 (-0%)
Previous Close $1.63    52 Week High $0.64 
Open $1.63    52 Week Low $0.10 
Day High $1.63    P/E N/A 
Day Low $1.63    EPS $0.00 
Volume 30